1. Home
  2. CYPH vs LFVN Comparison

CYPH vs LFVN Comparison

Compare CYPH & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cypherpunk Technologies Inc.

CYPH

Cypherpunk Technologies Inc.

SELL

Current Price

$3.33

Market Cap

73.3M

Sector

Health Care

ML Signal

SELL

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

HOLD

Current Price

$6.00

Market Cap

78.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYPH
LFVN
Founded
2011
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.3M
78.0M
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
CYPH
LFVN
Price
$3.33
$6.00
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $7.50
AVG Volume (30 Days)
★ 12.4M
28.2K
Earning Date
11-11-2026
11-03-2026
Dividend Yield
N/A
★ 3.35%
EPS Growth
★ 103.87
N/A
EPS
N/A
★ 0.40
Revenue
$1,500,000.00
★ $203,204,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$408.92
$1.34
P/E Ratio
★ N/A
$14.94
Revenue Growth
N/A
★ 1.86
52 Week Low
$0.49
$3.90
52 Week High
$4.19
$11.71

Technical Indicators

Market Signals
Indicator
CYPH
LFVN
Relative Strength Index (RSI) 57.30 43.28
Support Level $0.65 $5.93
Resistance Level $4.19 $6.06
Average True Range (ATR) 0.36 0.22
MACD -0.07 0.01
Stochastic Oscillator 87.17 71.65

Price Performance

Historical Comparison
CYPH
LFVN

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium, and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.

Share on Social Networks: